欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1550/003
药品名称
Persatul
活性成分
hydrochlorothiazide 12.5 mg
olmesartan medoxomil 40.0 mg
剂型
Film-coated tablet
上市许可持有人
Substipharm Développement
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
许可日期
2017/04/19
最近更新日期
2019/04/30
药物ATC编码
C09DA08 olmesartan medoxomil and diuretics
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
603987_603988_603989_603990_20170517_PAR_ACM
Date of last change:2024/09/06
Final Product Information
|
common_impack_DCP 1550_D195
Date of last change:2024/09/06
Final Product Information
|
PIL Davidol 20 mg 12_5 mg or 25 mg film coated tablets_DCP 1550_track_D195
Date of last change:2024/09/06
Final Product Information
|
PIL Davidol 40 mg 12_5 mg or 25 mg film coated tablets_DCP 1550_D195
Date of last change:2024/09/06
Final Product Information
|
SmPC Davidol 20mg HCTZ Substipharm 12_5 and 25mg film coated tablets_DCP 1550_D195
Date of last change:2024/09/06
Final Product Information
|
SmPC Davidol 40mg HCTZ 12_5 mg or 25 mg Substipharm film coated tablets_DCP1550_D195
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase